Colgate-Palmolive (NYSE:CL) is scheduled to be issuing its quarterly earnings data before the market opens on Friday, January 26th. Analysts expect the company to announce earnings of $0.75 per share for the quarter.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, October 27th. The company reported $0.73 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.73. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The company had revenue of $3.97 billion for the quarter, compared to analyst estimates of $3.94 billion. During the same period in the prior year, the firm posted $0.73 EPS. The company’s quarterly revenue was up 2.8% on a year-over-year basis. On average, analysts expect Colgate-Palmolive to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Shares of Colgate-Palmolive (CL) opened at $76.63 on Friday. The company has a debt-to-equity ratio of 24.42, a current ratio of 1.23 and a quick ratio of 0.92. Colgate-Palmolive has a 12 month low of $63.43 and a 12 month high of $77.29. The company has a market cap of $67,290.00, a price-to-earnings ratio of 29.59, a PEG ratio of 3.19 and a beta of 0.81.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, February 15th. Stockholders of record on Tuesday, January 23rd will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.09%. The ex-dividend date is Monday, January 22nd. Colgate-Palmolive’s dividend payout ratio is currently 61.78%.

In other Colgate-Palmolive news, Director Stephen I. Sadove sold 20,780 shares of the company’s stock in a transaction on Monday, November 6th. The shares were sold at an average price of $70.52, for a total transaction of $1,465,405.60. Following the transaction, the director now owns 36,268 shares in the company, valued at $2,557,619.36. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Victoria L. Dolan sold 10,000 shares of the company’s stock in a transaction on Thursday, November 9th. The stock was sold at an average price of $73.07, for a total transaction of $730,700.00. Following the transaction, the insider now owns 60,528 shares in the company, valued at approximately $4,422,780.96. The disclosure for this sale can be found here. Over the last three months, insiders have sold 181,950 shares of company stock worth $13,237,385. 1.02% of the stock is owned by insiders.

CL has been the topic of a number of analyst reports. Zacks Investment Research lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Tuesday, September 26th. Jefferies Group reaffirmed a “hold” rating and issued a $79.00 price objective on shares of Colgate-Palmolive in a research note on Thursday, September 28th. Morgan Stanley cut their target price on shares of Colgate-Palmolive from $84.00 to $83.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 31st. KeyCorp reissued a “hold” rating on shares of Colgate-Palmolive in a research note on Monday, October 16th. Finally, Deutsche Bank assumed coverage on shares of Colgate-Palmolive in a research note on Wednesday, December 13th. They set a “hold” rating and a $75.00 target price on the stock. Two equities research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and six have given a buy rating to the company’s stock. Colgate-Palmolive currently has an average rating of “Hold” and a consensus target price of $76.45.

TRADEMARK VIOLATION WARNING: “Colgate-Palmolive (CL) to Release Quarterly Earnings on Friday” was reported by American Banking News and is the property of of American Banking News. If you are accessing this story on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright laws. The legal version of this story can be read at

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Earnings History for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with's FREE daily email newsletter.